Free Trial

Tilray (TLRY) Competitors

Tilray logo
$0.86 -0.01 (-0.77%)
As of 10:50 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

TLRY vs. CRON, MNMD, USNA, SNDL, CDXC, ACB, BTMD, CGC, MDWD, and FTLF

Should you be buying Tilray stock or one of its competitors? The main competitors of Tilray include Cronos Group (CRON), Mind Medicine (MindMed) (MNMD), USANA Health Sciences (USNA), SNDL (SNDL), ChromaDex (CDXC), Aurora Cannabis (ACB), biote (BTMD), Canopy Growth (CGC), MediWound (MDWD), and FitLife Brands (FTLF). These companies are all part of the "medicinals & botanicals" industry.

Tilray vs.

Cronos Group (NASDAQ:CRON) and Tilray (NASDAQ:TLRY) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, media sentiment, earnings, institutional ownership, community ranking, valuation, dividends and profitability.

Cronos Group has a beta of 0.97, meaning that its share price is 3% less volatile than the S&P 500. Comparatively, Tilray has a beta of 2.07, meaning that its share price is 107% more volatile than the S&P 500.

Cronos Group currently has a consensus target price of $3.00, indicating a potential upside of 54.64%. Tilray has a consensus target price of $2.70, indicating a potential upside of 211.17%. Given Tilray's stronger consensus rating and higher probable upside, analysts plainly believe Tilray is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cronos Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Tilray
0 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.40

Tilray has a net margin of -30.95% compared to Cronos Group's net margin of -42.65%. Cronos Group's return on equity of -2.56% beat Tilray's return on equity.

Company Net Margins Return on Equity Return on Assets
Cronos Group-42.65% -2.56% -2.47%
Tilray -30.95%-4.40%-3.57%

Cronos Group received 16 more outperform votes than Tilray when rated by MarketBeat users. Likewise, 61.13% of users gave Cronos Group an outperform vote while only 59.26% of users gave Tilray an outperform vote.

CompanyUnderperformOutperform
Cronos GroupOutperform Votes
464
61.13%
Underperform Votes
295
38.87%
TilrayOutperform Votes
448
59.26%
Underperform Votes
308
40.74%

Cronos Group has higher earnings, but lower revenue than Tilray. Cronos Group is trading at a lower price-to-earnings ratio than Tilray, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cronos Group$111.23M6.67-$73.96M-$0.13-14.92
Tilray$210.48M3.87-$244.98M-$0.30-2.89

8.7% of Cronos Group shares are owned by institutional investors. Comparatively, 9.4% of Tilray shares are owned by institutional investors. 6.9% of Cronos Group shares are owned by company insiders. Comparatively, 0.9% of Tilray shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Tilray had 20 more articles in the media than Cronos Group. MarketBeat recorded 20 mentions for Tilray and 0 mentions for Cronos Group. Tilray's average media sentiment score of 0.44 beat Cronos Group's score of 0.00 indicating that Tilray is being referred to more favorably in the news media.

Company Overall Sentiment
Cronos Group Neutral
Tilray Neutral

Summary

Tilray beats Cronos Group on 10 of the 18 factors compared between the two stocks.

Get Tilray News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLRY vs. The Competition

MetricTilrayMedicinals & botanicals IndustryStaples SectorNASDAQ Exchange
Market Cap$813.60M$1.19B$16.25B$9.12B
Dividend YieldN/AN/A2.92%3.98%
P/E Ratio-2.8938.8316.5919.12
Price / Sales3.875.684.87119.58
Price / CashN/A10.3916.7338.24
Price / Book0.211.956.865.12
Net Income-$244.98M-$53.22M$709.20M$245.96M
7 Day Performance-6.98%-4.82%-0.11%-0.89%
1 Month Performance-25.84%-1.99%0.94%-0.51%
1 Year Performance-51.25%-12.35%8.79%16.50%

Tilray Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLRY
Tilray
2.7095 of 5 stars
$0.86
-0.8%
$2.70
+213.6%
-51.8%$809.20M$788.94M-2.882,650
CRON
Cronos Group
1.3106 of 5 stars
$1.97
-1.5%
$3.00
+52.3%
-12.2%$753.58M$87.24M-15.15450
MNMD
Mind Medicine (MindMed)
2.3788 of 5 stars
$9.89
+14.3%
$26.33
+166.3%
+61.3%$725.25MN/A-4.3840Gap Up
High Trading Volume
USNA
USANA Health Sciences
4.2218 of 5 stars
$31.73
+0.4%
$38.00
+19.8%
-34.4%$604.74M$921.01M11.211,800Upcoming Earnings
Analyst Downgrade
Analyst Revision
News Coverage
SNDL
SNDL
3.5607 of 5 stars
$1.86
flat
$3.25
+74.7%
+29.4%$488.77M$673.33M-6.002,516
CDXC
ChromaDex
4.5002 of 5 stars
$5.87
+5.2%
$8.00
+36.3%
+258.5%$448.35M$83.57M587.59120News Coverage
ACB
Aurora Cannabis
0.2592 of 5 stars
$6.31
-4.7%
N/A+68.9%$346.17M$200.35M126.231,073Gap Up
BTMD
biote
3.067 of 5 stars
$4.58
flat
$10.00
+118.3%
+3.2%$248.88M$185.36M17.62194
CGC
Canopy Growth
1.7939 of 5 stars
$1.89
flat
$2.00
+5.8%
-54.5%$246.51M$220.27M-0.381,029
MDWD
MediWound
1.2066 of 5 stars
$18.76
+0.8%
$27.50
+46.6%
+41.8%$202.42M$18.69M-6.4780
FTLF
FitLife Brands
4.4963 of 5 stars
$15.15
+0.9%
$20.00
+32.0%
+34.8%$69.84M$52.70M8.9620

Related Companies and Tools


This page (NASDAQ:TLRY) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners